ProjectSFB 1774/1 CARDDIAB – Liver endothelial dysfunction and its role in MASLD progression and cardiovascular…

Basic data

Acronym:
SFB 1774/1 CARDDIAB
Title:
Liver endothelial dysfunction and its role in MASLD progression and cardiovascular complications
Duration:
01/10/2026 to 30/09/2030
Abstract / short description:
MASLD is associated with type 2 diabetes and cardiovascular (CV) complications. Liver sinusoidal endothelial cells (LSEC) are fundamental for liver homeostasis and MASLD, as they release angiokines and nitric oxide (NO). Here we hypothesize that alterations in angiokines and NO metabolites released by LSEC promote MASLD and CV complications. We therefore investigate these signals in mice and humans with and without MASLD. We also analyze the extent by which MASLD and its CV complications are rescued by LSEC-specific reconstitution of selected angiokines and NO.
Keywords:
diabetes
Diabetes
mouse model
Mausmodell
metabolism
Metabolismus
Leber

Involved staff

Managers

Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science

Other staff

Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science

Local organizational units

Department of Pharmacy and Biochemistry
Faculty of Science
University of Tübingen

Funders

Bonn, Nordrhein-Westfalen, Germany

Cooperations

Düsseldorf, Nordrhein-Westfalen, Germany
Münster, Nordrhein-Westfalen, Germany
Düsseldorf, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.